NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Molecular Garden

Molecular Garden

Private
BerlinHealthcare & Life Scienceshttps://www.moleculargarden.com/

Last Round

Accelerator

Jun 3, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Molecular Garden is a biotechnology company that produces plant-derived ingredients through precision plant cell cultivation in bioreactors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologybiomanufacturingbioactive ingredientsplant cell cultivationlab-grown ingredientscellular agriculturemetabolic engineeringbioreactor cultivationsustainable cosmeticsclean beauty ingredientsprecision fermentationbotanical extractionCPG ingredientsbioprocess control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Garden Comparables

Compare Molecular Garden with similar companies based on industry and business-model similarity.

Molecular Garden comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chi Botanic
84%
Ayana Bio
84%
Novella Innovative Technology
79%

Molecular Garden Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 3, 2026

Key People

Founding team and executive leadership

Alessandro De Simone

Co-Founder & Chief Scientific Officer

Founding Team

Molecular Garden Investors

Notable investors and investment history

Molecular Garden investors
InvestorRounds
MassChallenge SwitzerlandAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 11, 2026

    Grew 300% QoQ from 1 to 4 employees.

Molecular Garden Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Molecular Garden Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Molecular Garden's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range4
Year FoundedN/A
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.